Japan’s contract drug rep ratio rose to 8.7% in FY2024 as the total number of regular reps continued to fall, the Japan Contract Sales Organization Association (JCSOA) reported in June. Amid industry downsizing, the roles and expectations placed on contract…
Avigan Interim Analysis Not Intended to Determine Efficacy, Research Sponsor Says on Reports
To read the full story
Related Article
- Fujifilm Inks Global Avigan Deal with Dr. Reddy’s, Global Response Aid
July 2, 2020
- Fujifilm’s Avigan COVID-19 Trial Might Continue into July
June 9, 2020
- Japan Drops May-End Goal for Avigan’s COVID-19 Approval
May 27, 2020
- Govt Won't Require Fujifilm-Sponsored Trial Data to Approve Avigan for COVID-19: Abe
May 18, 2020
- Kato Repeats May-End Goal for Avigan OK, Negative for Use in Mildly Ill Patients
May 11, 2020
ACADEMIA
- Japan Hypertension Society to Release Revised Treatment Guidelines in August
July 28, 2025
- Dust Mite Sublingual Immunotherapy Linked to Lower Antibiotic Use in Children
July 25, 2025
- Japan Embraces New AML Era with Tibsovo Debut, Says Hematologist
June 30, 2025
- Keytruda Label Update Unlocks First New Treatment in 14 Years for HER2-Positive Gastric Cancer: Oncologist
June 24, 2025
- Oncologist Hails Amgen’s Imdelltra as “First New Option in 20 Years” for SCLC
June 23, 2025
A recent conversation with a US biopharma senior director highlighted a critical talent gap: a strong demand for individuals with strategic management, critical thinking, and advanced business acumen-skills beyond traditional operational excellence. After the conversation, I rushed home and picked…
For the first time in many years, Japan appeared to have pivoted to a pro-innovation path with the FY2024 drug pricing reform. All eyes were apparently on this course change as seen in this year’s most-read story list, though the…
The Ministry of Health, Labor and Welfare (MHLW) posted the final report compiled by its pharmaceutical regulation panel on its website on April 24, providing cases of drugs that could be exempted from all-case post marketing surveillance (PMS).The MHLW plans…